NO20012860L - MRT contrast agent - Google Patents

MRT contrast agent

Info

Publication number
NO20012860L
NO20012860L NO20012860A NO20012860A NO20012860L NO 20012860 L NO20012860 L NO 20012860L NO 20012860 A NO20012860 A NO 20012860A NO 20012860 A NO20012860 A NO 20012860A NO 20012860 L NO20012860 L NO 20012860L
Authority
NO
Norway
Prior art keywords
contrast agent
mrt
mrt contrast
relates
bentonite
Prior art date
Application number
NO20012860A
Other languages
Norwegian (no)
Other versions
NO20012860D0 (en
Inventor
Wilfried Hiebl
Artur Frank
Original Assignee
Goldham Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goldham Pharma Gmbh filed Critical Goldham Pharma Gmbh
Publication of NO20012860D0 publication Critical patent/NO20012860D0/en
Publication of NO20012860L publication Critical patent/NO20012860L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen angår et MRT (magnetisk resonans- tomografi) kontrastmiddel med en viskositet på 500-2500 cP, som omfatter en suspensjon av kaolin, valgfritt kombinert med bentonitt i en citratbuffer, og oppfinnelsen angår en fremgangsmåte til fremstilling av MRT-kontrastmidler av denne typen.The invention relates to an MRT (magnetic resonance tomography) contrast agent having a viscosity of 500-2500 cP, comprising a suspension of kaolin, optionally combined with bentonite in a citrate buffer, and the invention relates to a process for preparing MRT contrast agents of this type.

NO20012860A 1998-12-11 2001-06-08 MRT contrast agent NO20012860L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19857345A DE19857345A1 (en) 1998-12-11 1998-12-11 MRI contrast media
PCT/EP1999/009459 WO2000035489A1 (en) 1998-12-11 1999-12-03 Magnetic resonance tomography contrast agent

Publications (2)

Publication Number Publication Date
NO20012860D0 NO20012860D0 (en) 2001-06-08
NO20012860L true NO20012860L (en) 2001-08-01

Family

ID=7890842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012860A NO20012860L (en) 1998-12-11 2001-06-08 MRT contrast agent

Country Status (19)

Country Link
EP (1) EP1137443B1 (en)
JP (1) JP2002532439A (en)
KR (1) KR20010081078A (en)
AT (1) ATE234119T1 (en)
AU (1) AU752874B2 (en)
BG (1) BG105545A (en)
CA (1) CA2353871A1 (en)
CZ (1) CZ20011522A3 (en)
DE (2) DE19857345A1 (en)
EE (1) EE200100291A (en)
HR (1) HRP20010307A2 (en)
HU (1) HUP0104429A2 (en)
IL (1) IL142916A0 (en)
NO (1) NO20012860L (en)
PL (1) PL348197A1 (en)
SK (1) SK6542001A3 (en)
TR (1) TR200101641T2 (en)
WO (1) WO2000035489A1 (en)
ZA (1) ZA200104691B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2621952C1 (en) * 2016-04-01 2017-06-08 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Method for computer-tomographic study of stomach

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
US4927624A (en) * 1987-11-19 1990-05-22 The University Of Rochester Clay magnetic resonance contrast agents for gastrointestinal comsumption or introduction
IL101492A0 (en) * 1992-04-03 1992-12-30 Shalom Levy Anti-skin rash preparation
US5424142A (en) * 1993-05-20 1995-06-13 E-Z-Em, Inc. Negative contrast agents for magnetic resonance imaging comprising barium sulfate and a clay

Also Published As

Publication number Publication date
ZA200104691B (en) 2002-07-31
NO20012860D0 (en) 2001-06-08
EE200100291A (en) 2002-08-15
SK6542001A3 (en) 2001-11-06
JP2002532439A (en) 2002-10-02
CZ20011522A3 (en) 2001-09-12
HUP0104429A2 (en) 2002-03-28
PL348197A1 (en) 2002-05-06
BG105545A (en) 2001-12-29
KR20010081078A (en) 2001-08-25
ATE234119T1 (en) 2003-03-15
EP1137443B1 (en) 2003-03-12
AU752874B2 (en) 2002-10-03
DE59904570D1 (en) 2003-04-17
WO2000035489A1 (en) 2000-06-22
DE19857345A1 (en) 2000-06-15
IL142916A0 (en) 2002-04-21
EP1137443A1 (en) 2001-10-04
HRP20010307A2 (en) 2002-06-30
CA2353871A1 (en) 2000-06-22
TR200101641T2 (en) 2001-10-22
AU1969900A (en) 2000-07-03

Similar Documents

Publication Publication Date Title
TW200512006A (en) A method for making a magnetic resonance (MR) imaging agent, a mr imaging contrast agent, a metnod for altering stability of a peptide and a modified peptide
NO950682L (en) Synthesis of N-substituted oligomers
EA200001129A3 (en) METHOD OF OBTAINING 4-CARBOXYAMINO-2-SUBSTITUTE-1,2,3,4-TETRAHYDROCHINOLINE
EP1009440A4 (en) Method for inhibiting immunostimulatory dna associated responses
DK0874645T3 (en) Perflouralkyl-containing metal complexes and their use in NMR diagnostics
WO2001031580A3 (en) Methods and devices for identifying patterns in biological systems
DK0836485T3 (en) Cascade-polymer complexes, processes for their preparation, and pharmaceutical agents containing them
DK1455596T3 (en) Capsule with quick dissolution and release
WO1998022136A3 (en) Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
AU8487998A (en) Novel apparatus and method for isolated pelvic perfusion
AU3877500A (en) Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof
WO2003016923A3 (en) Hydroxypyridonate and hydroxypyrimidinone chelating agents
PL306173A1 (en) Novel inclusion complexes, method of obtaining them and pharmaceutical agent
WO2001031579A3 (en) Methods and devices for identifying patterns in biological patterns
WO2003050260A3 (en) Streptavidin expressed gene fusions and methods of use thereof
DE60124289D1 (en) PROCESS FOR PREPARING 21-HYDROXY-6,19-OXIDOPROGESTERONE (21OH-6OP)
MXPA01008605A (en) Goodpasture antigen binding protein.
DE60034885D1 (en) ENZYME EYE AND METHOD FOR THE PRODUCTION THEREOF, ENZYME PREPARATION, PROTEASE PREPARATIONS AND PROTEASE-PRODUCING BACTERIUM
NO20012860L (en) MRT contrast agent
FI885312L (en) A method for determining one or more components of a reaction between a specifically binding protein and a corresponding binding agent from a test sample using at least one labeled component, a method for preparing the labeled component, and a test kit.......
DE69912827T2 (en) "LIGAND PRESENTING ASSEMBLY" (LPA), METHOD FOR THE PRODUCTION AND USE THEREOF
DE50006245D1 (en) METHOD FOR PRODUCING (1,1 ': 4', 1 '') TERPHENYL COMPOUNDS
DE68912809D1 (en) Process for the preparation of bis (2,2,6,6-tetramethyl-4-piperidyl) amine.
DK1095032T3 (en) Novel fluorescent CYP2D assay reagents
MXPA98005238A (en) Cardiovascular and thrombus imaging agents, methods and kits.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application